OPKO Health
OPK
$1.32
Share price
1.54%
Change (1 day)
-16.46%
Change (1 year)
Categories
OPKO Health (OPK) Fails to deliver data
Key failure to deliver metrics for OPKO Health :
- Last SEC data release: 2024-04-30
- Last 15 days FTD volume: $0.96 M
- Last 3 months FTD volume: $40.16 M
- Last year FTD volume: $49.72 M
Failures to deliver for OPKO Health (OPK) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for OPKO Health (OPK) - since 2013
Volume in USD (price x number of shares), data since 2013OPKO Health (OPK) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $46.84 M | 925.21% |
| 2023 | $4.56 M | -72.01% |
| 2022 | $16.32 M | -44.51% |
| 2021 | $29.41 M | -63.07% |
| 2020 | $79.64 M | 122.76% |
| 2019 | $35.75 M | -46% |
| 2018 | $66.21 M | -54.43% |
| 2017 | $0.14 B | -47.42% |
| 2016 | $0.27 B | 9.96% |
| 2015 | $0.25 B | -37.28% |
| 2014 | $0.40 B | 16.96% |
| 2013 | $0.34 B |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.13 B | $0.59 B | 🇺🇸 USA |
 Abbott Laboratories ABT | $10.62 M | $0.13 B | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $1.06 M | $0.14 B | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $0.23 B | $0.32 B | 🇺🇸 USA |
 LabCorp LH | $0.1 M | $48.7 M | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $3.35 M | $37.96 M | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $5.61 M | $30.31 M | 🇮🇱 Israel |
 Ardelyx ARDX | $10.24 M | $30.46 M | 🇺🇸 USA |